★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
Straumann Holding AG (STMN) Moat Analysis
Straumann Holding AG
STMN · SIX Swiss Exchange
Partial score covering 67% of segment weight.
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
Straumann is a dental-technology group focused on implantology, orthodontics and digital workflows. Implantology has the clearest moat: company-estimated global share above 35%, premium and challenger brands, and education at a scale of more than 370,000 doctors in 2025. Training reinforces familiarity but does not prevent clinicians from using multiple implant systems. ClearCorrect remains below 5% estimated share; its open workflow and outsourced Smartee production do not establish proprietary lock-in or a cost moat. Straumann AXS has growing adoption and an integrated scanner-software-services-consumables ecosystem, but its open-platform design and strong competitors cap moat strength. On 17 June 2026 the Group raised expected full-year core EBIT margin expansion to 140-170 basis points while maintaining high-single-digit organic-growth guidance; half-year results are due 19 August 2026.
Primary segment
Implantology (Tooth Replacement & Restoration)
Market structure
Oligopoly
Market share
35%-36% (reported)
HHI: —
Coverage
3 segments · 7 tags
Updated 2026-07-12
Segments
Implantology (Tooth Replacement & Restoration)
Dental implantology (tooth replacement and restoration solutions)
Revenue
—
Structure
Oligopoly
Pricing
moderate
Share
35%-36% (reported)
Peers
Orthodontics (Clear Aligner Solutions)
Clear aligner orthodontics (treatment planning + aligner manufacturing)
Revenue
—
Structure
Oligopoly
Pricing
weak
Share
2%-5% (reported)
Peers
Digital Dentistry & Prosthetics Workflow
Digital dentistry workflows (intraoral scanners, cloud platforms, CAD/CAM and chairside prosthetic production)
Revenue
—
Structure
Competitive
Pricing
moderate
Share
—
Peers
Moat Claims
Implantology (Tooth Replacement & Restoration)
Dental implantology (tooth replacement and restoration solutions)
Brand Trust
Demand
Brand Trust
Strength
Durability
Confidence
Evidence
Premium positioning and clinician adoption support willingness-to-pay; flagship innovations show strong uptake in the premium implant franchise.
Brand Trust moat: definition, examples, and stocks
Erosion risks
- Price controls / tenders (e.g., China VBP) compress premium pricing
- Feature/clinical evidence parity from competitors
- Brand damage from quality or safety issues
Leading indicators
- Implantology market share trend
- Premium mix (share of premium SKUs within implant sales)
- New product adoption (e.g., flagship implant system volumes)
Counterarguments
- Competitors have comparable clinical evidence and premium brands, limiting differentiation
- Patients and clinics may trade down in price-sensitive markets
Training Org Change Costs
Demand
Training Org Change Costs
Strength
Durability
Confidence
Evidence
Education programs and workflow tools reinforce clinician familiarity with Straumann systems; switching implant systems can require retraining and process changes.
Training Org Change Costs moat: definition, examples, and stocks
Erosion risks
- Standardized surgical workflows reduce brand-specific training needs
- DSOs standardize purchasing across brands based on price
- Increased use of guided surgery and digital planning reduces procedural variability
Leading indicators
- Training/course participation and certification counts
- Rep/clinical support coverage and engagement
- Clinic share-of-wallet and repeat ordering behavior
Counterarguments
- Clinicians can multi-source implants; retraining costs may be manageable
- Digital planning and standard kits can make switching easier over time
Orthodontics (Clear Aligner Solutions)
Clear aligner orthodontics (treatment planning + aligner manufacturing)
Partnerships referenced by the company include Smartee (manufacturing/efficiency) and DentalMonitoring (remote monitoring integration).
Insufficient segment-specific evidence to assign a moat claim.
Digital Dentistry & Prosthetics Workflow
Digital dentistry workflows (intraoral scanners, cloud platforms, CAD/CAM and chairside prosthetic production)
Interoperability Hub
Network
Interoperability Hub
Strength
Durability
Confidence
Evidence
Straumann positions AXS as a cloud platform connecting its solutions into integrated workflows, acting as a hub across scanning, planning, and treatment execution.
Interoperability Hub moat: definition, examples, and stocks
Erosion risks
- Open standards/interoperability reduce platform lock-in
- Clinics/labs prefer best-of-breed point solutions
- Regulatory/security incidents undermine trust in cloud workflows
Leading indicators
- Active users on the platform (clinicians/labs)
- Attach rate of scanners to platform workflows
- Software/service recurring revenue growth
Counterarguments
- Major incumbents and independents offer comparable end-to-end digital workflows
- If the platform is truly 'open', it may reduce exclusivity and monetization leverage
Ecosystem Complements
Network
Ecosystem Complements
Strength
Durability
Confidence
Evidence
Integrated hardware (scanners/printing), software, and consumables enable a bundled digital chairside workflow, increasing value as more components are adopted together.
Ecosystem Complements moat: definition, examples, and stocks
Erosion risks
- Hardware commoditization (scanners/printers) reduces differentiation
- Dental labs may resist vendor lock-in and demand open formats
- Competitors bundle at lower price points
Leading indicators
- Scanner installs and utilization
- Cross-sell rates (scanner -> software -> production/consumables)
- Renewal rates for software/services
Counterarguments
- Clinics can assemble similar workflows from multiple vendors
- Bundling can face pushback if any component is inferior to best-in-class alternatives
Evidence
strong demand for our premium and challenger implant brands
Official annual report commentary supports durable clinician demand for the implant portfolio.
With more than one million implants sold
High adoption of the flagship implant system indicates clinical trust and commercial pull.
over 10 700 educational activities and trained more than 370 000 doctors
Large education footprint supports clinician familiarity and process inertia.
further strengthening its leadership through education and clinical engagement
Shows education remains a current strategic lever for implantology share and clinician retention.
>35% (+1%)
Company-estimated 2025 global implantology market share on the addressable-market slide.
Showing 5 of 10 sources.
Risks & Indicators
Erosion risks
- Price controls / tenders (e.g., China VBP) compress premium pricing
- Feature/clinical evidence parity from competitors
- Brand damage from quality or safety issues
- Standardized surgical workflows reduce brand-specific training needs
- DSOs standardize purchasing across brands based on price
- Increased use of guided surgery and digital planning reduces procedural variability
Leading indicators
- Implantology market share trend
- Premium mix (share of premium SKUs within implant sales)
- New product adoption (e.g., flagship implant system volumes)
- Training/course participation and certification counts
- Rep/clinical support coverage and engagement
- Clinic share-of-wallet and repeat ordering behavior
Research STMN elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.